Repros Therapeutics (RPRX) Tops Q4 EPS by 3c
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.31), $0.03 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.31), $0.03 better than the analyst estimate of ($0.34).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.